![Dirk Huebner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Huebner
Technik-/Wissenschafts-/F&E-Leiter bei
APTEVO THERAPEUTICS INC.
Vermögen: 1 981 $ am 31.07.2026
Profil
Dirk Huebner is Chief Medical Officer & Senior Vice President at Aptevo Therapeutics, Inc. since 2025.
Formerly, Dr. Huebner was Executive Medical Director at Millennium Pharmaceuticals, Inc. in 2017, Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020, and Vice President at Boston Biomedical, Inc. from 2017 to 2018.
Education includes a doctorate from Freie Universität Berlin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.08.2026 | 482 ( 0.04% ) | 1 981 $ | 31.07.2026 |
Aktive Positionen von Dirk Huebner
| Unternehmen | Position | Beginn |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
Ehemalige bekannte Positionen von Dirk Huebner
| Unternehmen | Position | Ende |
|---|---|---|
| MERSANA THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Corporate Officer/Principal | 01.11.2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.08.2017 |
Ausbildung von Dirk Huebner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Commercial Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
